Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Neonc Technologies, Inc.
Neonc Technologies, Inc.
Seoul National University Bundang Hospital
Azienda Ospedaliero-Universitaria di Parma
Ocellaris Pharma, Inc.
Mayo Clinic
Universitair Ziekenhuis Brussel
TScan Therapeutics, Inc.
University of Pittsburgh
AVM Biotechnology Inc
Bicara Therapeutics
Leap Therapeutics, Inc.
Numab Therapeutics AG
Revolution Medicines, Inc.